Insider Trading Alert - MSFT, CHRW And CHE Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, July 31, 2014, 62 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $688.80 to $331,041,610.43.

Highlighted Stocks Traded by Insiders:

Microsoft (MSFT) - FREE Research Report

Gates William H Iii, who is Director at Microsoft, sold 7.6 million shares at $43.62 on July 31, 2014. Following this transaction, the Director owned 298.0 million shares meaning that the stake was reduced by 2.48% with the 7.6 million-share transaction.

The shares most recently traded at $43.15, down $0.47, or 1.09% since the insider transaction. Historical insider transactions for Microsoft go as follows:

  • 4-Week # shares sold: 12.5 million
  • 12-Week # shares sold: 12.5 million
  • 24-Week # shares sold: 43.8 million

The average volume for Microsoft has been 28.8 million shares per day over the past 30 days. Microsoft has a market cap of $360.0 billion and is part of the technology sector and computer software & services industry. Shares are up 15.37% year-to-date as of the close of trading on Thursday.

Microsoft Corporation develops, licenses, and supports software, services, and hardware devices. Its Windows division offers Windows operating system; Windows Services suite of applications and Web services, including Outlook.com and SkyDrive; Surface RT and Pro devices; and PC accessories. The stock currently has a dividend yield of 2.57%. The company has a P/E ratio of 16.6. Currently, there are 10 analysts who rate Microsoft a buy, no analysts rate it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MSFT - FREE

TheStreet Quant Ratings rates Microsoft as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, reasonable valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Microsoft Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

CH Robinson Worldwide (CHRW) - FREE Research Report

Campbell Ben G, who is VP-General Counsel & Secretary at CH Robinson Worldwide, sold 400 shares at $68.00 on July 31, 2014. Following this transaction, the VP-General Counsel & Secretary owned 37,614 shares meaning that the stake was reduced by 1.05% with the 400-share transaction.

The shares most recently traded at $67.60, down $0.40, or 0.59% since the insider transaction. Historical insider transactions for CH Robinson Worldwide go as follows:

  • 4-Week # shares bought: 400
  • 4-Week # shares sold: 4,832
  • 12-Week # shares bought: 400
  • 12-Week # shares sold: 6,032
  • 24-Week # shares bought: 400
  • 24-Week # shares sold: 6,032

The average volume for CH Robinson Worldwide has been 1.4 million shares per day over the past 30 days. CH Robinson Worldwide has a market cap of $10.2 billion and is part of the services sector and transportation industry. Shares are up 15.61% year-to-date as of the close of trading on Thursday.

C.H. Robinson Worldwide, Inc., a third party logistics company, provides freight transportation services and logistics solutions to companies in various industries worldwide. The stock currently has a dividend yield of 2.04%. The company has a P/E ratio of 25.0. Currently, there are 2 analysts who rate CH Robinson Worldwide a buy, 3 analysts rate it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CHRW - FREE

TheStreet Quant Ratings rates CH Robinson Worldwide as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, notable return on equity, increase in stock price during the past year and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CH Robinson Worldwide Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Chemed (CHE) - FREE Research Report

Lee Spencer S, who is executive vice president at Chemed, sold 2,000 shares at $102.28 on July 31, 2014. Following this transaction, the executive vice president owned 63,848 shares meaning that the stake was reduced by 3.04% with the 2,000-share transaction.

The shares most recently traded at $101.50, down $0.78, or 0.77% since the insider transaction. Historical insider transactions for Chemed go as follows:

  • 4-Week # shares sold: 229
  • 12-Week # shares sold: 6,978
  • 24-Week # shares sold: 28,814

The average volume for Chemed has been 215,800 shares per day over the past 30 days. Chemed has a market cap of $1.8 billion and is part of the health care sector and health services industry. Shares are up 32.93% year-to-date as of the close of trading on Thursday.

Chemed Corporation provides hospice and palliative care services in the United States. It operates in two segments, VITAS and Roto-Rooter. The company offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The stock currently has a dividend yield of 0.78%. The company has a P/E ratio of 21.8. Currently, there is 1 analyst who rates Chemed a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CHE - FREE

TheStreet Quant Ratings rates Chemed as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, revenue growth, notable return on equity and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Chemed Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Oil Slips From Three-Year Peak After Trump Tweets Anger at OPEC

Oil Slips From Three-Year Peak After Trump Tweets Anger at OPEC

Swiss Franc Slides to Three-Year Low as U.S. Sanctions on Russian Oligarchs Bite

Swiss Franc Slides to Three-Year Low as U.S. Sanctions on Russian Oligarchs Bite

GE Beats Earnings Estimates and 4 Other Stories You Must Know Friday Morning

GE Beats Earnings Estimates and 4 Other Stories You Must Know Friday Morning

General Electric, Honeywell, Wells Fargo and Qualcomm - 5 Things You Must Know

General Electric, Honeywell, Wells Fargo and Qualcomm - 5 Things You Must Know

Global Stocks Hit by Asia Tech Weakness, Oil Price Rally; U.S. Futures Slip

Global Stocks Hit by Asia Tech Weakness, Oil Price Rally; U.S. Futures Slip